CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: October 1, 2013
Result type: Reports
Project Number: SR0354-000
Product Line: Reimbursement Review

Generic Name: Aripiprazole

Brand Name: Abilify

Manufacturer: Bristol-Myers Squibb Canada

Therapeutic Area: Depression, Major Depressive Disorder

Indications: Depression, Major Depressive Disorder (MDD)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: October 22, 2014

Recommendation Type: Do not list